U.S. Proposal Estimates $9 Billion in Annual Medicare Advantage Recoveries
Key Facts
The Centers for Medicare & Medicaid Services estimated that the proposed audit methodology for Medicare Advantage plans could enable average recoveries of nearly $9 billion for each payment year, as part of a proposal to combat fraud, waste and abuse issued on November 16, 2026. The proposed rule was published in the Federal Register on November 19, stating that extrapolation would cover audits for payment year 2018 and subsequent years. This approach allows audit findings from a sample to be used to estimate overpayments at the contract level. The proposal covers Medicare, Medicaid, the Children’s Health Insurance Program and the Health Insurance Marketplace. The recovery estimate applies to Medicare Advantage overall and is not an estimate of what the government could recover from any one company.
The change centers on applying extrapolation to risk adjustment data audits, using sample findings to calculate amounts not owed at the contract level. CMS proposes not to apply the fee-for-service adjuster to these audits. The measure’s significance is based on findings from completed audits for payment years 2011–2013, which showed overpayments ranging from 5% to 8% among the plans audited. CMS Administrator Mehmet Oz said the agency is committed to ensuring that plans bill the government accurately. He added: "The administration appreciates the work Medicare Advantage plans do, but it is time for CMS to faithfully perform its duty to audit these plans and ensure they bill the government accurately."
The proposal also aims to expand reporting on indicators of fraud and abuse in Medicare Part C and Part D plans. In calendar year 2025, 46% of plan contracts reported referrals involving suspected or confirmed fraud, waste or abuse, according to the Federal Register; CMS proposes making this reporting mandatory. The agency also said that only 19% of contracts reported suspending payments based on credible allegations of fraud. It proposes expanding payment suspension reporting to cover all types of providers and suppliers. These requirements place greater monitoring and reporting responsibility on plan contracts as the agency seeks to strengthen oversight of federal funds.
The proposal also addresses updates to provider and supplier enrollment data, with CMS seeking to standardize the deadline for reporting any change at 30 calendar days. Current rules provide a 30-day deadline for critical changes, while the deadline is as long as 90 days for other types of changes. The agency estimates that the quantitative provisions together would result in nearly $90 billion in federal savings over 2027–2036. Over the same period, it estimates implementation costs of about $378.51 million. These figures are CMS estimates for the proposed provisions combined, while the $9 billion a year estimate concerns the Medicare Advantage audit methodology.
The plan comes as UnitedHealth reported consolidated revenue of $112.694 billion in the third quarter of 2026, compared with $113.161 billion in the same period of 2025. The company reported operating earnings of $6.563 billion, versus $4.315 billion a year earlier. Adjusted earnings per share also rose to $4.69 from $2.92. In the market, the company’s shares closed at $349.91 on November 18, after closing at $389.68 in the previous session. MarketWatch reported that the stock had fallen 20% over the five days before its report, published on November 19, as focus intensified on tighter scrutiny of Medicare Advantage.
As background to the audits, CMS previously estimated annual recoveries of about $425 million after extrapolated audits for payment year 2018 began. The new estimate, averaging about $9 billion for each payment year, is tied to the proposed methodology for expanding the use of sample findings at the contract level. CMS is accepting public comments on the proposal for 60 calendar days after its publication in the Federal Register. It set January 19, 2027, as the deadline for submitting comments. After the comment period ends, the next regulatory step will be to complete consideration of the proposal and draft the final rule.